Obvius Investment BV's Carmustine Obvius (carmustine) Receives Approval in Europe. Carmustine Obvius is a cancer medicine that is used, on its own or with other cancer medicines and treatments, to treat the following types of cancer
TUALATIN, Ore., Jan. 18, 2019 /PRNewswire/ -- Obvius announced today that BACnet IP Logging is now a standard feature on the AcquiSuite™ line of data acquisition servers. This new feature complements the AcquiSuite, creating a cost-effective solution ideal for leveraging a building's existing metrology. This additional feature to the AcquiSuite's industry leading data acquisition technology empowers energy management professionals to maximize efficiency and reduce both redundant hardware and lengthy integration projects.